Dr. Ash Tewari: "Drug May Extend Survival for Men with Advanced Prostate Cancer"
A new hormone therapy drug for men with prostate cancer may increase survival a bit and delay progression of the disease in men who have advanced prostate cancer that has been resistant to standard hormonal therapies, a new study suggests. "This study's findings are exciting, and may give us another tool to fight this cancer," said Ashutosh Tewari, MB, BS, Chairman of the Milton and Carroll Petrie Department of Urology at the Icahn School of Medicine at Mount Sinai. "And it was safe, with some minor side effects but nothing unusual." Learn more
Immunotherapy After Bladder Cancer Surgery Shows Excellent Cancer-free Survival Rates
May 14, 2022 View All Press ReleasesMount Sinai Receives $1 Million Grant for Prostate Cancer Research
Dec 05, 2019 View All Press Releases